The Heart and Lung Research Center at Mayo Clinic is focused on advancing innovative therapeutics and novel diagnostics to treat and prevent cardiovascular and lung disease.
Motivating the center's faculty and staff is the high global prevalence of cardiovascular and lung disease. There is a compelling need to study the underlying causes of these diseases and create new methods of prevention and treatment, especially given that heart disease continues to be the No. 1 cause of death worldwide.
The Heart and Lung Research Center is organized into two main domains, cardiovascular disease and lung disease, and can support discoveries all the way to drug, device and diagnostic approval. Within these domains are specific programs related to discovery, innovative therapeutics and novel diagnostics.
A major goal of the Heart and Lung Research Center is to enable translational research, which includes promoting entrepreneurship and commercialization. The center has a unique entrepreneurship program that may lead to breakthrough therapies and diagnostics that contribute to its overall mission of reducing the burden of cardiovascular and lung disease.